Enomoto, K., Hirayama, S., Kumashiro, N., Jing, X., Kimura, T., Tamagawa, S., . . . Hotomi, M. (2021). Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models. Cancers (Basel).

Enomoto, Keisuke, Shun Hirayama, Naoko Kumashiro, Xuefeng Jing, Takahito Kimura, Shunji Tamagawa, Ibu Matsuzaki, Shin-Ichi Murata, und Muneki Hotomi. "Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models." Cancers (Basel) 2021.

Enomoto, Keisuke, et al. "Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models." Cancers (Basel) 2021.